ResMed Inc. (NYSE: RMD) had its price target raised by analysts at Bank of America Co. from $240.00 to $270.00. They now have a "buy" rating on the stock.
ResMed Inc. (RMD)
Last resmed inc. earnings: 4/30 04:05 pm
Check Earnings Report
US:NYSE Investor Relations:
investors.resmed.com/investor-relations/default.aspx
Company Research
Source: MarketBeat
Impact Snapshot
Event Time:
RMD
Last Price
Price Change
Price Change%
Volume Shares
Max Up
Max Down
%
Volume Ratio
Performance Comparison
Updated
Event Day
Stock performance from the time of news release until the following 4pm ET market close
|
Last price at news event
|
Since Event
Multi-day stock performance from the time of the news release
|
---|---|---|
EVENT DAY
Stock performance from the time of news release until the following 4pm ET market close
|
LAST
PRICE AT NEWS EVENT |
SINCE EVENT
Multi-day stock performance from the time of the news release
|
Last Price | ||
VWAP | ||
High:
|
Max Up |
High:
|
Low:
|
Max Down |
Low:
|
%
|
Post news range |
%
|
|
Price change |
|
|
Price Change Percentage |
|
|
S&P 500 (SPX) |
|
%
|
Volume ratio |
%
|
Volume | ||
Ticks | ||
|
Avg transaction size |
|
Don't Miss Out On The Next BIG Stock Move
Event day
Event Day Chart will not be displayed beyond 90-day period of the event
Performance since event
Time And Velocity Analysis
Be the first to know
Opt in for alerts from News Quantifed
Sign Up Today
Opt-in for
RMD alerts
Learn More With NQ
Reading the Impact Report
Help Me Understand This Data
Help Me Understand This Data
How NQ Works
What is news-based trading?
And why is it so successful?
And why is it so successful?
Movers & Shakers
The biggest gainers and losers and WHY it moved
RMD alerts
High impacting ResMed Inc. news events
Weekly update
A roundup of the hottest topics
RMD
News
- ResMed Inc. (NYSE: RMD) was upgraded by analysts at Baird R W to a "strong-buy" rating.MarketBeat
- ResMed (NYSE:RMD) Eyes Growth with Board Expansion and Solid Earnings Despite Freight Cost Challenges [Yahoo! Finance]Yahoo! Finance
- Pottery Barn Launches Nightstand Designed To Fit Your CPAP Machine [Forbes]Forbes
- Baird starts ResMed at outperform, cites growing sleep apnea market Sep. 24, 2024 2:18 PM ET By: Val Brickates Kennedy , SA News Editor [Seeking Alpha]Seeking Alpha
- ResMed Inc. (NYSE: RMD) is now covered by analysts at Robert W. Baird. They set an "outperform" rating and a $280.00 price target on the stock.MarketBeat
RMD
Earnings
- 8/1/24 - Beat
RMD
Sec Filings
- 9/13/24 - Form 4
- 9/12/24 - Form 144
- 9/10/24 - Form 4
- RMD's page on the SEC website